← All insiders

BRNS

Barinthus Biotherapeutics plc

49 transactions on file, per SEC Form 4 filings.

Oxford Science Enterprises plc

10% owner · 2026-09-09

U-Tender

$977K

Wright Robin

director · 2026-09-09

D-Return

$79K

Wright Robin

director · 2026-09-09

D-Return

$44K

Wright Robin

director · 2026-09-09

D-Return

$46K

Wright Robin

director · 2026-09-09

D-Return

$20K

Wright Robin

director · 2026-09-09

D-Return

$0K

Wright Robin

director · 2026-09-09

D-Return

$0K

Wright Robin

director · 2026-09-09

D-Return

$584K

Scheeren Joseph

director · 2026-09-09

D-Return

$0K

Scheeren Joseph

director · 2026-09-09

D-Return

$584K

Scheeren Joseph

director · 2026-09-09

D-Return

$79K

Scheeren Joseph

director · 2026-09-09

D-Return

$44K

Scheeren Joseph

director · 2026-09-09

D-Return

$46K

Scheeren Joseph

director · 2026-09-09

D-Return

$20K

Phillips Anne M.

director · 2026-09-09

D-Return

$0K

Phillips Anne M.

director · 2026-09-09

D-Return

$584K

Phillips Anne M.

director · 2026-09-09

D-Return

$79K

Phillips Anne M.

director · 2026-09-09

D-Return

$44K

Phillips Anne M.

director · 2026-09-09

D-Return

$46K

Phillips Anne M.

director · 2026-09-09

D-Return

$20K

Morgon Pierre A.

director · 2026-09-09

D-Return

$0K

Morgon Pierre A.

director · 2026-09-09

D-Return

$0K

Morgon Pierre A.

director · 2026-09-09

D-Return

$584K

Morgon Pierre A.

director · 2026-09-09

D-Return

$79K

Morgon Pierre A.

director · 2026-09-09

D-Return

$44K

Morgon Pierre A.

director · 2026-09-09

D-Return

$46K

Morgon Pierre A.

director · 2026-09-09

D-Return

$20K

Hooftman Leon

Chief Medical Officer · 2026-09-09

Award

$0K

Hooftman Leon

Chief Medical Officer · 2026-09-09

D-Return

$0K

Hooftman Leon

Chief Medical Officer · 2026-09-09

D-Return

$390K

Hooftman Leon

Chief Medical Officer · 2026-09-09

D-Return

$140K

Hammacher Alex

director · 2026-09-09

D-Return

$0K

Hammacher Alex

director · 2026-09-09

D-Return

$584K

Hammacher Alex

director · 2026-09-09

D-Return

$79K

Hammacher Alex

director · 2026-09-09

D-Return

$44K

Hammacher Alex

director · 2026-09-09

D-Return

$46K

Hammacher Alex

director · 2026-09-09

D-Return

$20K

Enright William

Chief Executive Officer · 2026-09-09

D-Return

$0K

Enright William

Chief Executive Officer · 2026-09-09

D-Return

$3.0M

Enright William

Chief Executive Officer · 2026-09-09

D-Return

$4.0M

Enright William

Chief Executive Officer · 2026-09-09

D-Return

$1.1M

Enright William

Chief Executive Officer · 2026-09-09

D-Return

$1.6M

Enright William

Chief Executive Officer · 2026-09-09

D-Return

$600K

DAWES KAREN A

director · 2026-09-09

D-Return

$0K

DAWES KAREN A

director · 2026-09-09

D-Return

$584K

DAWES KAREN A

director · 2026-09-09

D-Return

$79K

DAWES KAREN A

director · 2026-09-09

D-Return

$44K

DAWES KAREN A

director · 2026-09-09

D-Return

$46K

DAWES KAREN A

director · 2026-09-09

D-Return

$20K

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is BRNS actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.

Analyze BRNS